MitoImmune Therapeutics

Mighty Therapeutics

This company develops mitochondrial-targeted therapies for patients with rare genetic conditions like Barth syndrome and common age-related diseases.

MuReva Phototherapy

The company develops an intraoral light therapy device to prevent and treat oral mucositis in cancer patients undergoing radiation and chemotherapy.

MitoRx Therapeutics

MitoRx Therapeutics develops small-molecule therapies restoring mitochondrial health to treat patients with high-risk obesity and degenerative diseases.

Evommune

This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.

Paeanbio

The company develops mitochondria-based biopharmaceuticals and cell therapies to treat inflammatory, autoimmune and oncology patients.

Ouro Medicines

This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.

Endurance Bio

This biotechnology company develops oral small molecule therapeutics for patients with neurodegenerative and metabolic diseases to restore mitochondrial and lysosomal health.

MPC Therapeutics

This biotechnology company develops mitochondrial pyruvate carrier targeted therapies and small molecule supplements to enhance cellular immunotherapies for cancer patients and healthcare providers.